{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:26:34Z","timestamp":1782447994092,"version":"3.54.5"},"reference-count":57,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Heart failure (HF) is a prevalent cardiovascular condition among the elderly population, with an incidence rate that continues to rise annually, highlighting the urgent need for effective therapeutic interventions. Sustained activation of Toll-like receptor 4 (TLR4) may contribute to left ventricular dysfunction and adverse cardiac remodeling through the induction of myocardial inflammation and oxidative stress \u2013 pathological processes that closely align with the hallmark features of HF. Preclinical studies in animal models have demonstrated that TLR4 deficiency improves cardiac function in aged mice; however, the precise role and underlying mechanisms of TLR4 in human HF remain poorly understood. This study aims to test the central hypothesis that TLR4 serves as a critical molecular link between chronic inflammation and the pathophysiology of HF. HF was induced in 18-month-old male C57BL\/6J mice via continuous subcutaneous infusion of isoproterenol (ISO, 30 mg\/kg\/day) over a period of 3 weeks. Thereafter, mice received daily intraperitoneal injections of the TLR4 inhibitor TAK-242 (2 mg\/kg), deoxyribonuclease I (DNase I, 5 mg\/kg), or the peptidylarginine deiminase 4 (PAD4) inhibitor GSK484 (4 mg\/kg) for 7 consecutive days. Cardiac function was assessed using a ultrasound imaging system. HE staining and Masson staining were employed to evaluate myocardial pathological changes and collagen deposition. ELISA was performed to measure serum levels of myeloperoxidase-DNA (MPO-DNA), neutrophil elastase-DNA (NE-DNA), cTnI, NT-proBNP, IL-1\u03b2, IL-6 and TNF-\u03b1. Immunofluorescence staining was performed to detect the co-localization levels of Ly6G with myeloperoxidase (MPO) and citrullinated histone H3 (cit-H3) in myocardial tissue, in order to assess the formation level of neutrophil extracellular traps (NETs). Western blot were utilized to determine the expression level of TLR4 protein. The expression of TLR4 was significantly upregulated in the myocardial tissue of aged HF mice. Inhibition of TLR4 not only markedly improved cardiac function but also alleviated pathological damage to myocardial tissue and reduced collagen fiber deposition. Concurrently, it also decreased the serum levels of MPO-DNA, NE-DNA, NT-proBNP, cTnI, and inflammatory factors. Moreover, the colocalization levels of Ly6G with MPO or cit-H3 in myocardial tissue was also diminished. These findings were consistent with the effects observed following DNase I and GSK484 interventions. Targeting TLR4 can mitigate inflammatory responses and enhance cardiac function in HF mice by inhibiting NETs formation.<\/jats:p>","DOI":"10.33549\/physiolres.935671","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:28:17Z","timestamp":1773224897000},"page":"29","source":"Crossref","is-referenced-by-count":1,"title":["Targeting the Toll-Like Receptor 4 Ameliorates Heart Failure in Aged Mice by Inhibiting the Formation of Neutrophil Extracellular Traps"],"prefix":"10.33549","author":[{"given":"H","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1.\tJi H, Kwan AC, Chen MT, Ouyang D, Ebinger JE, Bell SP, et al. Sex differences in myocardial and vascular aging. Circ Res 2022;130:566-577. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319902","DOI":"10.1161\/CIRCRESAHA.121.319902"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2.\tCrespo-Leiro MG, Barge-Caballero E. Advanced Heart Failure: Definition, Epidemiology, and Clinical Course. Heart Fail Clin 2021;17:533-545. https:\/\/doi.org\/10.1016\/j.hfc.2021.06.002","DOI":"10.1016\/j.hfc.2021.06.002"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.\tFerrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 2018;15:505-522. https:\/\/doi.org\/10.1038\/s41569-018-0064-2","DOI":"10.1038\/s41569-018-0064-2"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.\tLv J, Zhang C, Liu X, Gu C, Liu Y, Gao Y, et al. An aging-related immune landscape in the hematopoietic immune system. Immun Ageing 2024;21:3. https:\/\/doi.org\/10.1186\/s12979-023-00403-2","DOI":"10.1186\/s12979-023-00403-2"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5.\tKumar V, Barrett JE. Toll-Like Receptors (TLRs) in Health and Disease: An Overview. Handb Exp Pharmacol 2022;276:1-21. https:\/\/doi.org\/10.1007\/164_2021_568","DOI":"10.1007\/164_2021_568"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6.\tBarill\u00e0 F, Cammisotto V, Bartimoccia S, Loffredo L, Nocella C, Bruno N, et al. Toll-like receptor 4 activation in platelets from myocardial infarction patients. Thromb Res 2022;209:33-40. https:\/\/doi.org\/10.1016\/j.thromres.2021.11.019","DOI":"10.1016\/j.thromres.2021.11.019"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7.\tTian L, Jarrah M, Herz H, Chu Y, Xu Y, Tang Y, Yuan J, Mokadem M. Toll-like Receptor 4 Differentially Modulates Cardiac Function in Response to Chronic Exposure to High-Fat Diet and Pressure Overload. Nutrients 2023;15:5139. https:\/\/doi.org\/10.3390\/nu15245139","DOI":"10.3390\/nu15245139"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8.\tLiu H, Chu S, Wu Z. Loss of toll-like receptor 4 ameliorates cardiovascular dysfunction in aged mice. Immun Ageing 2021;18:42. https:\/\/doi.org\/10.1186\/s12979-021-00251-y","DOI":"10.1186\/s12979-021-00251-y"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9.\tYe Z, Zhong L, Zhu S, Wang Y, Zheng J, Wang S, et al. The P-selectin and PSGL-1 axis accelerates atherosclerosis via activation of dendritic cells by the TLR4 signaling pathway. Cell Death Dis 2019;10:507. https:\/\/doi.org\/10.1038\/s41419-019-1736-5","DOI":"10.1038\/s41419-019-1736-5"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10.\tStark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol 2021;18:666-682. https:\/\/doi.org\/10.1038\/s41569-021-00552-1","DOI":"10.1038\/s41569-021-00552-1"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11.\tCarnevale R, Sciarretta S, Valenti V, di Nonno F, Calvieri C, Nocella C, et al. Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction. Eur Heart J 2020;41:3156-3165. https:\/\/doi.org\/10.1093\/eurheartj\/ehz893","DOI":"10.1093\/eurheartj\/ehz893"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12.\tKain V, Halade GV. Role of neutrophils in ischemic heart failure. Pharmacol Ther 2020;205:107424. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107424","DOI":"10.1016\/j.pharmthera.2019.107424"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13.\tMa Y, Yabluchanskiy A, Iyer RP, Cannon PL, Flynn ER, Jung M, et al. Temporal neutrophil polarization following myocardial infarction. Cardiovasc Res 2016;110:51-61. https:\/\/doi.org\/10.1093\/cvr\/cvw024","DOI":"10.1093\/cvr\/cvw024"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14.\tChan L, Karimi N, Morovati S, Alizadeh K, Kakish JE, Vanderkamp S, et al. The Roles of Neutrophils in Cytokine Storms. Viruses 2021;13:2318. https:\/\/doi.org\/10.3390\/v13112318","DOI":"10.3390\/v13112318"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15.\tClark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007;13:463-469. https:\/\/doi.org\/10.1038\/nm1565","DOI":"10.1038\/nm1565"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16.\tKim HJ, Kim H, Lee JH, Hwangbo C. Toll-like receptor 4 (TLR4): new insight immune and aging. Immun Ageing 2023;20:67. https:\/\/doi.org\/10.1186\/s12979-023-00383-3","DOI":"10.1186\/s12979-023-00383-3"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"17.\tCarminita E, Crescence L, Panicot-Dubois L, Dubois C. Role of Neutrophils and NETs in Animal Models of Thrombosis. Int J Mol Sci 2022;23:1411. https:\/\/doi.org\/10.3390\/ijms23031411","DOI":"10.3390\/ijms23031411"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18.\tDumont BL, Neagoe PE, Charles E, Villeneuve L, Ninni S, Tardif JC, et al. Low-Density Neutrophils and Neutrophil Extracellular Traps (NETs) Are New Inflammatory Players in Heart Failure. Can J Cardiol 2024;40:1524-1535. https:\/\/doi.org\/10.1016\/j.cjca.2024.03.018","DOI":"10.1016\/j.cjca.2024.03.018"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19.\tChang SC, Ren S, Rau CD, Wang JJ. Isoproterenol-Induced Heart Failure Mouse Model Using Osmotic Pump Implantation. Methods Mol Biol 2018;1816:207-220. https:\/\/doi.org\/10.1007\/978-1-4939-8597-5_16","DOI":"10.1007\/978-1-4939-8597-5_16"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"20.\tChang C, Hu L, Sun S, Song Y, Liu S, Wang J, Li P. Regulatory role of the TLR4\/JNK signaling pathway in sepsis\u2011induced myocardial dysfunction. Mol Med Rep 2021;23:334. https:\/\/doi.org\/10.3892\/mmr.2021.11973","DOI":"10.3892\/mmr.2021.11973"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21.\tYang K, Gao R, Chen H, Hu J, Zhang P, Wei X, et al. Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition. Eur Heart J 2024;45:1662-1680. https:\/\/doi.org\/10.1093\/eurheartj\/ehae205","DOI":"10.1093\/eurheartj\/ehae205"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"22.\tWu X, You D, Pan M, Weng M, Xie Q, Guan Y, et al. Knockout of the C3a receptor protects against renal ischemia reperfusion injury by reduction of NETs formation. Cell Mol Life Sci 2023;80:322. https:\/\/doi.org\/10.1007\/s00018-023-04967-6","DOI":"10.1007\/s00018-023-04967-6"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"23.\tGupta K, Bagang N, Singh G, Laddi L. Rat Model of Isoproterenol-Induced Myocardial Injury. Methods Mol Biol 2024;2803:123-136. https:\/\/doi.org\/10.1007\/978-1-0716-3846-0_9","DOI":"10.1007\/978-1-0716-3846-0_9"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"24.\tLiu M, Liu P, Zheng B, Liu Y, Li L, Han X, et al. Cardioprotective effects of alantolactone on isoproterenol-induced cardiac injury and cobalt chloride-induced cardiomyocyte injury. Int J Immunopathol Pharmacol 2022;36:20587384211051993. https:\/\/doi.org\/10.1177\/20587384211051993","DOI":"10.1177\/20587384211051993"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"25.\tMasuda S, Nakazawa D, Shida H, Miyoshi A, Kusunoki Y, Tomaru U, Ishizu A. NETosis markers: Quest for specific, objective, and quantitative markers. Clin Chim Acta 2016;459:89-93. https:\/\/doi.org\/10.1016\/j.cca.2016.05.029","DOI":"10.1016\/j.cca.2016.05.029"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26.\tZhao H, Liang Y, Sun C, Zhai Y, Li X, Jiang M, et al. Dihydrotanshinone I Inhibits the Lung Metastasis of Breast Cancer by Suppressing Neutrophil Extracellular Traps Formation. Int J Mol Sci 2022;23:15180. https:\/\/doi.org\/10.3390\/ijms232315180","DOI":"10.3390\/ijms232315180"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"27.\tShen Z, Gu J, Jiang B, Long H, Li Z, Chen C, et al. Glycyrrhizin inhibits LPS-induced neutrophil-like release of NETs. Am J Transl Res 2024;16:5507-5515. https:\/\/doi.org\/10.62347\/LARN2372","DOI":"10.62347\/LARN2372"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"28.\tLa Franca E, Manno G, Ajello L, Di Gesaro G, Min\u00e0 C, Visconti C, et al. Physiopathology and Diagnosis of Congestive Heart Failure: Consolidated Certainties and New Perspectives. Curr Probl Cardiol 2021;46:100691. https:\/\/doi.org\/10.1016\/j.cpcardiol.2020.100691","DOI":"10.1016\/j.cpcardiol.2020.100691"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"29.\tKhan A, Johnson DK, Carlson S, Hocum-Stone L, Kelly RF, Gravely AA, et al. NT-Pro BNP Predicts Myocardial Injury Post-vascular Surgery and is Reduced with CoQ(10): A Randomized Double-Blind Trial. Ann Vasc Surg 2020;64:292-302. https:\/\/doi.org\/10.1016\/j.avsg.2019.09.017","DOI":"10.1016\/j.avsg.2019.09.017"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"30.\tKumar S, Griffith N, Walter D, Swett M, Raman V, Vargas JD, et al. Characterization of Myocardial Injury With High-Sensitivity Troponin. Tex Heart Inst J 2023;50:e238108. https:\/\/doi.org\/10.14503\/THIJ-23-8108","DOI":"10.14503\/THIJ-23-8108"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"31.\tCrapnell RD, Dempsey NC, Sigley E, Tridente A, Banks CE. Electroanalytical point-of-care detection of gold standard and emerging cardiac biomarkers for stratification and monitoring in intensive care medicine - a review. Mikrochim Acta 2022;189:142. https:\/\/doi.org\/10.1007\/s00604-022-05186-9","DOI":"10.1007\/s00604-022-05186-9"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"32.\tZhu CS, Wang W, Qiang X, Chen W, Lan X, Li J, Wang H. Endogenous Regulation and Pharmacological Modulation of Sepsis-Induced HMGB1 Release and Action: An Updated Review. Cells 2021;10:2220. https:\/\/doi.org\/10.3390\/cells10092220","DOI":"10.3390\/cells10092220"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"33.\tDemkow U. Molecular Mechanisms of Neutrophil Extracellular Trap (NETs) Degradation. Int J Mol Sci 2023;24:4896. https:\/\/doi.org\/10.3390\/ijms24054896","DOI":"10.3390\/ijms24054896"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"34.\tMolinaro R, Yu M, Sausen G, Bichsel CA, Corbo C, Folco EJ, et al. Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity. Cardiovasc Res 2021;117:2652-2663. https:\/\/doi.org\/10.1093\/cvr\/cvab074","DOI":"10.1093\/cvr\/cvab074"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"35.\tRosa GM, Scagliola R, Ghione P, Valbusa A, Brunelli C, Carbone F, et al. Predictors of cardiovascular outcome and rehospitalization in elderly patients with heart failure. Eur J Clin Invest 2019;49:e13044. https:\/\/doi.org\/10.1111\/eci.13044","DOI":"10.1111\/eci.13044"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"36.\tLe D, Grams ME, Coresh J, Shin JI. Sacubitril-Valsartan in Patients Requiring Hemodialysis. JAMA Netw Open 2024;7:e2429237. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.29237","DOI":"10.1001\/jamanetworkopen.2024.29237"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"37.\tAdams J, Mosler C. Safety and efficacy considerations amongst the elderly population in the updated treatment of heart failure: a review. Expert Rev Cardiovasc Ther 2022;20:529-541. https:\/\/doi.org\/10.1080\/14779072.2022.2098118","DOI":"10.1080\/14779072.2022.2098118"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"38.\tAdamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol 2020;17:269-285. https:\/\/doi.org\/10.1038\/s41569-019-0315-x","DOI":"10.1038\/s41569-019-0315-x"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"39.\tGirerd N, Cleland J, Anker SD, Byra W, Lam CSP, Lapolice D, et al. Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction. Sci Rep 2022;12:8574. https:\/\/doi.org\/10.1038\/s41598-022-12385-0","DOI":"10.1038\/s41598-022-12385-0"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"40.\tEfentakis P, Varela A, Lamprou S, Papanagnou ED, Chatzistefanou M, Christodoulou A, et al. Implications and hidden toxicity of cardiometabolic syndrome and early-stage heart failure in carfilzomib-induced cardiotoxicity. Br J Pharmacol 2024;181:2964-2990. https:\/\/doi.org\/10.1111\/bph.16391","DOI":"10.1111\/bph.16391"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"41.\tBiasucci LM, La Rosa G, Pedicino D, D'Aiello A, Galli M, Liuzzo G. Where Does Inflammation Fit? Curr Cardiol Rep 2017;19:84. https:\/\/doi.org\/10.1007\/s11886-017-0896-0","DOI":"10.1007\/s11886-017-0896-0"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"42.\tVaez H, Soraya H, Garjani A, Gholikhani T. Toll-Like Receptor 4 (TLR4) and AMPK Relevance in Cardiovascular Disease. Adv Pharm Bull 2023;13:36-47. https:\/\/doi.org\/10.34172\/apb.2023.004","DOI":"10.34172\/apb.2023.004"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"43.\tYu L, Feng Z. The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure. Mediators Inflamm 2018;2018:9874109. https:\/\/doi.org\/10.1155\/2018\/9874109","DOI":"10.1155\/2018\/9874109"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"44.\tZhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther 2022;7:78. https:\/\/doi.org\/10.1038\/s41392-022-00925-z","DOI":"10.1038\/s41392-022-00925-z"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"45.\tLi S, Navia-Pelaez JM, Choi SH, Miller YI. Macrophage inflammarafts in atherosclerosis. Curr Opin Lipidol 2023;34:189-195. https:\/\/doi.org\/10.1097\/MOL.0000000000000888","DOI":"10.1097\/MOL.0000000000000888"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"46.\tLi Z, Yu Z, Cui S, Hu S, Li B, Chen T, Qu C, Yang B. AMPA receptor inhibition alleviates inflammatory response and myocardial apoptosis after myocardial infarction by inhibiting TLR4\/NF-\u03baB signaling pathway. Int Immunopharmacol 2024;133:112080. https:\/\/doi.org\/10.1016\/j.intimp.2024.112080","DOI":"10.1016\/j.intimp.2024.112080"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"47.\tQi B, Li T, Luo H, Hu L, Feng R, Wang D, et al. Reticulon 3 deficiency ameliorates post-myocardial infarction heart failure by alleviating mitochondrial dysfunction and inflammation. MedComm (2020) 2024;5:e503. https:\/\/doi.org\/10.1002\/mco2.503","DOI":"10.1002\/mco2.503"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"48.\tMutua V, Gershwin LJ. A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics. Clin Rev Allergy Immunol 2021;61:194-211. https:\/\/doi.org\/10.1007\/s12016-020-08804-7","DOI":"10.1007\/s12016-020-08804-7"},{"key":"ref48","unstructured":"49.\tNatorska J, Z\u0105bczyk M, Undas A. Neutrophil extracellular traps (NETs) in cardiovascular diseases: From molecular mechanisms to therapeutic interventions. Kardiol Pol 2023;81:1205-1216. https:\/\/doi.org\/10.33963\/v.kp.98520"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"50.\tLu Y, Chen W, Guo Y, Wang Y, Wang L, Zhang Y. Risk factors for short-term mortality in elderly hip fracture patients with complicated heart failure in the ICU: A MIMIC-IV database analysis using nomogram. J Orthop Surg Res 2023;18:829. https:\/\/doi.org\/10.1186\/s13018-023-04258-7","DOI":"10.1186\/s13018-023-04258-7"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"51.\tZhang Y, Li X, Dai Y, Han Y, Wei X, Wei G, et al. Neutrophil N1 polarization induced by cardiomyocyte-derived extracellular vesicle miR-9-5p aggravates myocardial ischemia\/reperfusion injury. J Nanobiotechnology 2024;22:632. https:\/\/doi.org\/10.1186\/s12951-024-02902-w","DOI":"10.1186\/s12951-024-02902-w"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"52.\tEl-Awaisi J, Kavanagh DP, Rink MR, Weston CJ, Drury NE, Kalia N. Targeting IL-36 improves age-related coronary microcirculatory dysfunction and attenuates myocardial ischemia\/reperfusion injury in mice. JCI Insight 2022;7:e155236. https:\/\/doi.org\/10.1172\/jci.insight.155236","DOI":"10.1172\/jci.insight.155236"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"53.\tCassatella MA, \u00d6stberg NK, Tamassia N, Soehnlein O. Biological Roles of Neutrophil-Derived Granule Proteins and Cytokines. Trends Immunol 2019;40:648-664. https:\/\/doi.org\/10.1016\/j.it.2019.05.003","DOI":"10.1016\/j.it.2019.05.003"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"54.\tBlasco A, Coronado MJ, Vela P, Mart\u00edn P, Solano J, Ramil E, et al. Prognostic Implications of Neutrophil Extracellular Traps in Coronary Thrombi of Patients with ST-Elevation Myocardial Infarction. Thromb Haemost 2022;122:1415-1428. https:\/\/doi.org\/10.1055\/a-1709-5271","DOI":"10.1055\/a-1709-5271"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"55.\tLiu Y, Zhang X, Chen S, Wang J, Yu S, Li Y, et al. Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4. Clin Mol Hepatol 2022;28:522-539. https:\/\/doi.org\/10.3350\/cmh.2022.0039","DOI":"10.3350\/cmh.2022.0039"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"56.\tZuo H, Yang M, Ji Q, Fu S, Pu X, Zhang X, Wang X. Targeting Neutrophil Extracellular Traps: A Novel Antitumor Strategy. J Immunol Res 2023;2023:5599660. https:\/\/doi.org\/10.1155\/2023\/5599660","DOI":"10.1155\/2023\/5599660"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"57.\tLiu Y, Pu X, Qin X, Gong J, Huang Z, Luo Y, et al. Neutrophil Extracellular Traps Regulate HMGB1 Translocation and Kupffer Cell M1 Polarization During Acute Liver Transplantation Rejection. Front Immunol 2022;13:823511. https:\/\/doi.org\/10.3389\/fimmu.2022.823511","DOI":"10.3389\/fimmu.2022.823511"}],"container-title":["Physiological Research"],"original-title":[],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:28:35Z","timestamp":1773224915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2026\/75_29.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":57,"URL":"https:\/\/doi.org\/10.33549\/physiolres.935671","relation":{},"ISSN":["0862-8408","1802-9973"],"issn-type":[{"value":"0862-8408","type":"print"},{"value":"1802-9973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]}}}